Fernando Jerkovich
9PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Dec 30, 2025
Short-Term BRAF Inhibition with Dabrafenib induced redifferentiation in a subset of patients with BRAF V600E-Mutant papillary thyroid carcinoma.Fabián Pitoia, Fernando Jerkovich, Martina Rodrigo
|May 21, 2024
Ten years' real-life experience on the use of multikinase inhibitors in patients with advanced differentiated thyroid cancer.Fernando Jerkovich, Soledad Capalbo, Erika Abelleira
|May 20, 2024
Three-year effect of bisphosphonates on bone mineral density after denosumab withdrawal: observations from a real-world study.Vanina Farias, Fernando Jerkovich, Andrea Morejón Barragán
|Nov 28, 2023
Dynamic risk assessment in patients with differentiated thyroid cancer.Erika Abelleira, Fernando Jerkovich
|Sep 13, 2023
Twenty-four months of follow-up in women with rebound-associated vertebral fractures after discontinuation of denosumab: a single-centre case series.Dolores Clifton Goldney, Carolina Pelegrin, Fernando Jerkovich
|Aug 30, 2023
Advances in the management of anaplastic thyroid carcinoma: transforming a life-threatening condition into a potentially treatable disease.Inés Califano, Anabella Smulever, Fernando Jerkovich
Pageof 2